55%, respectively) ( Figure 5 ), but these differences did not reach statistical significance due to the small sample size. 4 Discussion There is currently a lack of effective treatments for refractory VF/pVT, which is considered a critical status ( Shih et al., 2007 ; Sakai et al., 2010 ; Reynolds et al., 2013 ; Soar et al., 2019 ).
← all excerpts
The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China.
1
—
—